Core Alternative Capital’s Amgen AMGN Stock Holding History

Core Alternative Capital’s Portfolio AMGN Stock Details AMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.14M	Sell	3,151 -170	-5%	-$58.2K	0.34%	65
2026 Q1	$1.17M	Sell	3,321 -332	-9%	-$118K	0.35%	64
2025 Q4	$1.2M	Buy	3,653 +308	+9%	+$97.7K	0.33%	60
2025 Q3	$944K	Sell	3,345 -756	-18%	-$219K	0.27%	62
2025 Q2	$1.15M	Sell	4,101 -1,008	-20%	-$286K	0.31%	63
2025 Q1	$1.59M	Sell	5,109 -4,029	-44%	-$1.19M	0.38%	64
2024 Q4	$2.38M	Sell	9,138 -1,796	-16%	-$533K	0.5%	59
2024 Q3	$3.52M	Sell	10,934 -2,525	-19%	-$826K	0.68%	54
2024 Q2	$4.21M	Sell	13,459 -4,919	-27%	-$1.45M	0.84%	48
2024 Q1	$5.23M	Sell	18,378 -6,709	-27%	-$1.96M	0.94%	46
2023 Q4	$7.23M	Sell	25,087 -10,745	-30%	-$2.93M	1.24%	38
2023 Q3	$9.63M	Sell	35,832 -4,266	-11%	-$1.06M	1.49%	32
2023 Q2	$8.9M	Sell	40,098 -8,993	-18%	-$2.09M	1.3%	38
2023 Q1	$11.9M	Sell	49,091 -5,123	-9%	-$1.26M	1.58%	36
2022 Q4	$14.2M	Buy	54,214 +5,973	+12%	+$1.6M	1.81%	32
2022 Q3	$10.9M	Buy	48,241 +19,003	+65%	+$4.61M	1.73%	36
2022 Q2	$7.11M	Buy	29,238 +3,098	+12%	+$759K	1.68%	34
2022 Q1	$6.32M	Sell	26,140 -10,147	-28%	-$2.33M	1.69%	37
2021 Q4	$7.91M	Buy	36,287 +1,447	+4%	+$305K	1.59%	38
2021 Q3	$7.41M	Buy	34,840 +3,954	+13%	+$910K	1.56%	38
2021 Q2	$7.53M	Buy	30,886 +5,222	+20%	+$1.28M	1.75%	27
2021 Q1	$6.38M	Buy	25,664 +1,077	+4%	+$257K	1.82%	26
2020 Q4	$5.65M	Buy	24,587 +2,862	+13%	+$660K	1.69%	32
2020 Q3	$5.52M	Sell	21,725 -2,956	-12%	-$732K	1.88%	19
2020 Q2	$5.82M	Buy	24,681 +1,184	+5%	+$270K	1.82%	23
2020 Q1	$4.76M	Buy	23,497 +12,491	+113%	+$2.73M	1.67%	35
2019 Q4	$2.65M	Buy	+11,006	New	+$2.43M	2.43%	4

Other funds holding AMGN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

Core Alternative Capital's AMGN Position: Q2 2026 in Review

Core Alternative Capital reduced its Amgen (AMGN) stake by 5.1% in Q2 2026, selling an estimated $58.2K and leaving 3,151 shares worth $1.14M. The position accounts for 0.34% of the portfolio, ranked #65.

Core Alternative Capital first reported a position in AMGN in Q4 2019 and has held it in 27 quarters since. The position peaked at $14.2M in Q4 2022. 3,164 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

Core Alternative Capital held 3,151 shares of Amgen worth $1.14M as of Q2 2026.
Core Alternative Capital sold 170 Amgen shares in Q2 2026, an estimated $58.2K.
Amgen made up 0.34% of Core Alternative Capital's portfolio in Q2 2026, its #65 holding.
Core Alternative Capital first reported a position in Amgen in Q4 2019 and has held it in 27 quarters since.
Core Alternative Capital's Amgen position peaked at $14.2M in Q4 2022.
3,164 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Core Alternative Capital's 13F filing for Q2 2026, filed 14 Aug 2026.